Latest Breaking News On - Timothy bretherton - Page 1 : comparemela.com

JP Jenkins Ltd: Lord David Prior Appointed as Chair of e-therapeutics Board of Directors

JP Jenkins Ltd Lord David Prior Appointed as Chair of e-therapeutics' Board of Directors 23-May-2024 / 08:32 GMT/BST The issuer is solely responsible for

City ofUnited kingdomNew yorkUnited statesLazard freresTimothy brethertonAli mortazaviTrevor jonesNovo nordisk sustainability advisory councilUnited kingdom life sciences council toCare quality commissionLehman brothersImperial collegeNovo nordiskJp jenkins ltdUniversity college london hospitals

Lord David Prior Appointed as Chair of e-therapeutics Board of Directors | Company Announcement

Lord David Prior Appointed as Chair of e-therapeutics Board of Directors | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesCity ofAli mortazaviTimothy brethertonTrevor jonesLazard freresUnited kingdom life sciences council toCambridge life sciences councilNovo nordisk sustainability advisory councilNorwich university hospitalsCare quality commissionImperial collegeUniversity college london hospitalsCambridge university

Result of General Meeting | Company Announcement

Investegate announcements from Result of General Meeting

United kingdomCity ofVadim alexandre rob reesAli mortazaviTimothy brethertonMatthew johnson caroline roweRepresentative of prosper capitalSp angel corporate financeFinancial conduct authorityNational securityNovo nordiskGeneral meetingInvestment actRichard griffiths subscriptionInfinitx limitedAppointed representative

Investegate | Company Announcement

Investegate announcements from Total Voting Rights

City ofUnited kingdomTimothy brethertonVadim alexandre rob reesAli mortazaviNovo nordiskSp angel corporate financeFinancial conduct authority disclosureInvestment market of the london stock exchangeFinancial conduct authorityTransparency rulesHarry davies ballCorporate financeRob reesCorporate brokingTeos therapeutics

E therapeutics : Interim Results for the financial year 2023/2024 -October 26, 2023 at 02:03 am EDT

Interim Results for the financial year 2023/2024 Interim results for the six months to 31 July 2023 Six months of progress with positive proof-of-concept data.

United kingdomCity ofUnited statesMichael brethertonAli mortazaviTimothy brethertonTeos therapeutics incEuropean union withdrawalRegulatory information serviceInterim resultsTeos therapeuticsChief financial officerNon executive directorNon executive directorsChief executive officerMarket abuse regulations